EMILY COX: Open Payments
NPI 1871019471 · ELIZABETH, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 29 payments from 20 companies in 2025. Trend: 2023 $410 · 2024 $839 · 2025 $808
Food & beverage: $714Education: $94
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 2 | $196 |
| SANOFI-AVENTIS U.S. LLC | 1 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Astellas Pharma US Inc | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Aveo Pharmaceuticals, Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| BeOne Medicines USA, Inc. | 2 | $37 |
| Genentech USA, Inc. | 1 | $23 |
Products named: EYLEA HD, SARCLISA, Enhertu, CALQUENCE, FOTIVDA, BRUKINSA, Stivarga, Padcev.
Industry payments across LA — which companies pay providers there.
